Annual Cash & Cash Equivalents
$103.71 M
+$70.01 M+207.73%
September 30, 2024
Summary
- As of February 8, 2025, EPIX annual cash & cash equivalents is $103.71 million, with the most recent change of +$70.01 million (+207.73%) on September 30, 2024.
- During the last 3 years, EPIX annual cash & cash equivalents has fallen by -$34.12 million (-24.75%).
- EPIX annual cash & cash equivalents is now -24.75% below its all-time high of $137.82 million, reached on September 30, 2021.
Performance
EPIX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$103.71 M
+$17.72 M+20.61%
September 30, 2024
Summary
- As of February 8, 2025, EPIX quarterly cash and cash equivalents is $103.71 million, with the most recent change of +$17.72 million (+20.61%) on September 30, 2024.
- Over the past year, EPIX quarterly cash and cash equivalents has increased by +$17.72 million (+20.61%).
- EPIX quarterly cash and cash equivalents is now -31.57% below its all-time high of $151.56 million, reached on March 31, 2021.
Performance
EPIX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EPIX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +207.7% | +20.6% |
| 3 y3 years | -24.8% | -24.8% |
| 5 y5 years | +94.5% | +125.8% |
EPIX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.8% | +207.7% | -14.3% | +207.7% |
| 5 y | 5-year | -24.8% | +207.7% | -31.6% | +207.7% |
| alltime | all time | -24.8% | +6466.8% | -31.6% | +6466.8% |
ESSA Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $103.71 M(+207.7%) | $103.71 M(+20.6%) |
| Jun 2024 | - | $85.99 M(-6.2%) |
| Mar 2024 | - | $91.68 M(+159.4%) |
| Dec 2023 | - | $35.34 M(+4.9%) |
| Sep 2023 | $33.70 M(-41.0%) | $33.70 M(-12.4%) |
| Jun 2023 | - | $38.47 M(-13.2%) |
| Mar 2023 | - | $44.30 M(-13.5%) |
| Dec 2022 | - | $51.22 M(-10.3%) |
| Sep 2022 | $57.08 M(-58.6%) | $57.08 M(-15.9%) |
| Jun 2022 | - | $67.87 M(-21.3%) |
| Mar 2022 | - | $86.24 M(-28.8%) |
| Dec 2021 | - | $121.06 M(-12.2%) |
| Sep 2021 | $137.82 M(+144.7%) | $137.82 M(-5.1%) |
| Jun 2021 | - | $145.19 M(-4.2%) |
| Mar 2021 | - | $151.56 M(+188.8%) |
| Dec 2020 | - | $52.48 M(-6.8%) |
| Sep 2020 | $56.32 M(+5.6%) | $56.32 M(+54.4%) |
| Jun 2020 | - | $36.48 M(-8.6%) |
| Mar 2020 | - | $39.91 M(-13.1%) |
| Dec 2019 | - | $45.93 M(-13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | $53.32 M(+259.6%) | $53.32 M(+993.9%) |
| Jun 2019 | - | $4.87 M(-43.3%) |
| Mar 2019 | - | $8.60 M(-29.4%) |
| Dec 2018 | - | $12.17 M(-17.9%) |
| Sep 2018 | $14.83 M(+274.7%) | $14.83 M(-17.9%) |
| Jun 2018 | - | $18.06 M(-16.7%) |
| Mar 2018 | - | $21.69 M(+1061.3%) |
| Dec 2017 | - | $1.87 M(-52.8%) |
| Sep 2017 | $3.96 M(-56.0%) | $3.96 M(-46.0%) |
| Jun 2017 | - | $7.33 M(-41.9%) |
| Mar 2017 | - | $12.62 M(+16.2%) |
| Dec 2016 | - | $10.86 M(+20.9%) |
| Sep 2016 | $8.99 M(+468.9%) | $8.99 M(-27.4%) |
| Jun 2016 | - | $12.38 M(-22.3%) |
| Mar 2016 | - | $15.93 M(+510.7%) |
| Dec 2015 | - | $2.61 M(+65.2%) |
| Sep 2015 | $1.58 M(-57.3%) | $1.58 M(-74.7%) |
| Jun 2015 | - | $6.24 M(-40.3%) |
| Mar 2015 | - | $10.44 M(+203.0%) |
| Dec 2014 | - | $3.45 M(-6.9%) |
| Sep 2014 | $3.70 M | $3.70 M |
FAQ
- What is ESSA Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ESSA Pharma?
- What is ESSA Pharma annual cash & cash equivalents year-on-year change?
- What is ESSA Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ESSA Pharma?
- What is ESSA Pharma quarterly cash and cash equivalents year-on-year change?
What is ESSA Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of EPIX is $103.71 M
What is the all time high annual cash & cash equivalents for ESSA Pharma?
ESSA Pharma all-time high annual cash & cash equivalents is $137.82 M
What is ESSA Pharma annual cash & cash equivalents year-on-year change?
Over the past year, EPIX annual cash & cash equivalents has changed by +$70.01 M (+207.73%)
What is ESSA Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EPIX is $103.71 M
What is the all time high quarterly cash and cash equivalents for ESSA Pharma?
ESSA Pharma all-time high quarterly cash and cash equivalents is $151.56 M
What is ESSA Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, EPIX quarterly cash and cash equivalents has changed by +$17.72 M (+20.61%)